首页> 美国卫生研究院文献>Annals of Oncology >A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer

【2h】

A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer

机译：S-1加口服亚叶酸钙与S-1单药治疗吉西他滨难治性晚期胰腺癌的II期随机研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundWe evaluated the efficacy and toxicity of adding oral leucovorin (LV) to S-1 when compared with S-1 monotherapy in patients with gemcitabine-refractory pancreatic cancer (PC).

机译：背景我们评估了吉西他滨难治性胰腺癌（PC）患者与S-1单药治疗相比，向S-1中添加口服亚叶酸（LV）的疗效和毒性。

著录项

期刊名称 Annals of Oncology
作者
M. Ueno; T. Okusaka; Y. Omuro; H. Isayama; A. Fukutomi; M. Ikeda; N. Mizuno; K. Fukuzawa; M. Furukawa; H. Iguchi; K. Sugimori; J. Furuse; K. Shimada; T. Ioka; S. Nakamori; H. Baba; Y. Komatsu; M. Takeuchi; I. Hyodo; N. Boku;
展开▼
作者单位

展开▼
年(卷),期 -1(27),3
年度 -1
页码 502–508
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
phase II study S-1 leucovorin gemcitabine-refractory pancreatic cancer pancreatic resection albumin;

机译：II期研究;S-1;亚叶酸钙;吉西他滨难治性胰腺癌;胰腺切除术;白蛋白;

相似文献

外文文献
中文文献

1. A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer [J] . Ueno M., Okusaka T., Omuro Y., Annals of oncology: official journal of the European Society for Medical Oncology . 2016,第3期

机译：S-1加口服亚叶酸钙与S-1单药治疗吉西他滨难治性晚期胰腺癌的随机II期研究
2. TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial) [J] . Ioka Tatsuya, Ueno Makoto, Ueno Hideki, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2019,第期

机译：TAS-118（S-1加白光伏素）对吉西他滨 - 难治晚期胰腺癌患者的S-1：随机，开放标签，第3阶段研究（葡萄试验）
3. S-1 as monotherapy or in combination with leucovorin as second-line treatment in gemcitabine-refractory advanced pancreatic cancer: A randomized, open-label, Multicenter, Phase II study [J] . GeF., XuN., BaiY., The oncologist . 2014,第11期

机译：S-1单药治疗或联合亚叶酸治疗二线治疗吉西他滨难治性晚期胰腺癌：一项随机，开放标签，多中心，II期研究
4. S-1/CDDP/Lentinan Combination Chemotherapy for Inoperable Advanced Gastric Cancer [C] . Shoichi Nagahashi, Hidekazu Suzuki, Toshifumi Hib International Gastric Cancer Congress . 2005

机译：S-1 / CDDP / Lentinan组合化疗，可管理的胃癌无法操作
5. A Study of Erlotinib Monotherapy and in Combination with Pembrolizumab in Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer [D] . Liu, Qiong. 2021

机译：Erlotinib单疗法和蛋白质在先前未处理阶段I-IIIA非小细胞肺癌中的研究
6. S-1 as Monotherapy or in Combination With Leucovorin as Second-Line Treatment in Gemcitabine-Refractory Advanced Pancreatic Cancer: A Randomized Open-Label Multicenter Phase II Study [O] . Feijiao Ge, Nong Xu, Yuxian Bai, 2014

机译：吉西他滨难治性晚期胰腺癌单药治疗或联合白细胞素二线治疗的S-1：一项随机开放标签多中心II期研究
7. S-1 monotherapy versus S-1 combination therapy in gemcitabine-refractory advanced pancreatic cancer [O] . Sheng Zhong, Shuai Qie, Liu Yang, 2017

机译：S-1单疗法与S-1组合治疗吉西滨 - 难治性晚期胰腺癌

A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer

摘要

著录项

相似文献

相关主题

期刊订阅